Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Pharma
AZ, Daiichi tout Enhertu win in earlier, broader HER2-low cancer
After spearheading the HER2-low category in breast cancer, Enhertu has shown it could be useful in tumors with even lower expression of HER2.
Angus Liu
Apr 29, 2024 10:38am
Novartis halts recruitment of trials for cancer drug Kisqali
Apr 10, 2024 11:09am
New Gilead hub exposes realities of metastatic breast cancer
Mar 11, 2024 3:30pm
Eli Lilly hit with Verzenio flop in prostate cancer
Feb 7, 2024 10:44am
Pfizer pumps $15M into ACS' cancer screening health equity push
Feb 6, 2024 5:26am
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am